Siboulet A, Bohbot J M, Lhuillier N, Siboulet A, Catalan F
Sex Transm Dis. 1984 Oct-Dec;11(4 Suppl):391-5. doi: 10.1097/00007435-198410001-00019.
The results obtained with single-dose (2.5 g of thiamphenicol) therapy of gonorrhea in 50,000 patients are reported. Male patients included recent cases of acute or subacute urethritis and uncomplicated cases; all female patients had uncomplicated gonorrhea. Asymptomatic gonorrhea in both men and women was included in the therapy trial in all cases when "epidemiological" treatment was necessary. Tolerance of thiamphenicol was excellent; we observed only 62 cases of gastralgia or nausea and 12 cases of generalized pruritus reaction. No hematologic side effect was reported. The prescribed dose does not conceal incubating syphilis since 211 cases of recent syphilis were observed. Failures are reported year by year from 1961 to 1982 and, on the average, failure rates for men and women were 3.42% and 3.24%, respectively.
报告了50000例淋病患者单剂量(2.5克甲砜霉素)治疗的结果。男性患者包括近期急性或亚急性尿道炎病例以及无并发症病例;所有女性患者均有无并发症的淋病。当需要进行“流行病学”治疗时,无论男性还是女性的无症状淋病均纳入治疗试验。甲砜霉素的耐受性极佳;我们仅观察到62例胃痛或恶心病例以及12例全身性瘙痒反应。未报告血液学副作用。规定剂量不会掩盖潜伏梅毒,因为观察到211例近期梅毒病例。报告了1961年至1982年逐年的治疗失败情况,平均而言,男性和女性的失败率分别为3.42%和3.24%。